Results 301 to 310 of about 23,893,303 (352)
Some of the next articles are maybe not open access.
Antileukotriene Drugs in the Management of Asthma
JAMA, 19981the mortality and morbidity associated with this disease have not appreciably declined. 2 It continues to be imperative to develop new approaches to asthma therapy. Antileukotriene drugs are a novel form of asthma pharmacotherapy and the first new treatment strategy for chronic asthma in 20 years. In experimental studies, cysteinyl leukotrienes (LTC4,
openaire +2 more sources
Managing Drug–Drug Interactions in Older Adults
The Journal of Clinical Pharmacology, 2023Zhu, Zhou +3 more
openaire +2 more sources
Update on Drug Management of Refractory Epilepsy in Tuberous Sclerosis Complex
Pediatric Drugs, 2020Emma A. van der Poest Clement +3 more
semanticscholar +1 more source
Biologic drugs in wound management
Journal of Wound Care, 2015The role of dermatologists in chronic wound management is increasing. They play a crucial role in the differential diagnosis of an atypical wound where wound and skin biopsies are mandatory. Because of this dermatopathologists have developed specific immunostaining techniques, which offer greater choice in the armamentarium of diagnostics, while ...
openaire +2 more sources
Drug Allergy Management on the Move
The Journal of Allergy and Clinical Immunology: In Practice, 2021Demoly, Pascal, Ramsey, Allison
openaire +3 more sources
Identification and management of drug allergy
Nursing Standard, 2018This article describes the signs and symptoms of drug allergy, and explains the effects that it can have on patient care. It outlines the risk factors for the development of drug allergy, along with the mechanisms by which allergic reactions are mediated.
openaire +2 more sources
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
Ca-A Cancer Journal for Clinicians, 2022Shanu Modi +2 more
exaly
&bgr;-lactam Therapeutic Drug Management in the PICU*
Critical Care Medicine, 2017Jeffrey J. Cies +3 more
semanticscholar +1 more source
[Management of antiretroviral drug toxicity].
Enfermedades infecciosas y microbiologia clinica, 2011Highly active antiretroviral therapy (HAART)-associated toxicity has been the most important limiting factor of the doubtless efficacy of this treatment. HAART-associated toxicity can have two kinds of temporal profiles; early toxicity, also known as tolerability, and long-term or chronic toxicity. Both types of toxicity are of foremost importance, not
Domingo, P, Lozano, F
openaire +2 more sources